Jack Chan's Weekly Precious Metals Update
Source: Streetwise Reports  (1/23/18)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets.
More >

Four Companies to Watch as the Gold Market Turns Upward
Source: Ron Struthers for Streetwise Reports  (1/23/18)
Ron Struthers of Struthers Resource Stock Report discusses the downfall of cryptocurrencies and the rise of gold, and presents four gold companies he is adding to his selection list. More >

Gold on the Move
Source: Rudi Fronk and Jim Anthony for Streetwise Reports  (1/22/18)
Since bottoming on December 11, 2017, at $1,242, gold has tacked on nearly $100 to its price. Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss what they see going on. More >

Anaconda Sitting on a Gold Mine
Source: Bob Moriarty for Streetwise Reports  (1/19/18)
Bob Moriarty of 321 Gold sees a lot of potential in this company's Nova Scotia and Newfoundland projects. More >

Regenerative Medicine Company's China Deal is 'Dramatically Transformational'
Source: Streetwise Reports  (1/18/18)
Echelon Wealth Partners detailed the terms and impact of this cell therapy developer's recent alliance in Asia. More >

Turnarounds Coming at Three Resource Companies? 
Source: Adrian Day for Streetwise Reports  (1/18/18)
Adrian Day of Adrian Day Asset Management provides updates on three resource companies with recent developments, one of which he deems a good buy now. 
More >

Several Milestones on Horizon for 'Top Pick' Immunotherapy Firm
Source: Streetwise Reports  (1/17/18)
Douglas Loe, an analyst with Echelon Partners, outlined the reasons this biotech deserves Top Pick status. More >

Tesla Model 3 and Chevy Bolt Are Straining the LIB Market
Source: Ron Struthers for Streetwise Reports  (1/17/18)
With sales of Tesla's Model 3 and Chevy's Bolt taking off, Ron Struthers of Struthers Resource Stock Report looks at the effects on the lithium and graphite markets for EV batteries. More >

Never Underestimate the Replacement Power of Equities Within a (HYPER) Inflationary Spiral
Source: Michael J. Ballanger for Streetwise Reports  (1/17/18)
Michael Ballanger discusses why he believes the U.S. stock market is defying gravity with a record-breaking nine years without a significant correction. More >

A Candidate for 'Deal of the Year' in British Columbia
Source: The Critical Investor for Streetwise Reports  (1/17/18)
The Critical Investor profiles a base metal developer with a project in British Columbia that recently signed a major funding agreement with Wheaton Precious Metals. More >

Junior E&P Begins Drilling in Oklahoma's STACK in Area with Monster Well Potential
Source: Streetwise Reports  (1/16/18)
A junior E&P with prime land in Oklahoma's STACK play uses a land swap to jump-start its drilling in an area that is seeing off-the-charts production as oil prices continue to rise. More >

'Revenue Build' in 2018 Anticipated for Energy Firm
Source: Streetwise Reports  (1/16/18)
Mackie Research Capital Corp. analyst Nikhil Thadani explained how a recent milestone may signify the start of a revenue growth spurt for this supplier of power electronics for energy storage systems. More >

Test for Personalized Approach to Hodgkin's Lymphoma Treatment Entering Final Stages Before Commercialization
Source: Streetwise Reports  (1/16/18)
One analyst believes 2018 could mark a 'dramatic turnaround' for this biotech company, which is at the forefront of using three-dimensional telomere analysis to personalize medical treatment. More >

'Grossly Undervalued' Miner Enters 2018 with Abundant News about Its Argentinian Projects
Source: Streetwise Reports  (1/16/18)
A small-cap miner moving forward on its prospects in Argentina has caught the attention of several industry watchers. More >

Thoughts on Novo
Source: Bob Moriarty for Streetwise Reports  (1/15/18)
With shares of Novo Resources on a rollercoaster since the summer, Bob Moriarty of 321 Gold discusses the company's latest moves. More >

Exciting News with More to Come
Source: Adrian Day for Streetwise Reports  (1/15/18)
Money manager Adrian Day provides updates for a handful of companies in his portfolio. More >

Jack Chan's Weekly Precious Metals Update
Source: Jack Chan for Streetwise Reports  (1/15/18)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets, and says that a falling dollar is supportive for metal prices.
More >

Gold in Bulgaria? Drilling Says 'Yes'
Source: Streetwise Reports  (1/11/18)
It's been full speed ahead for this TSX.V-listed gold explorer in Bulgaria, and the drill bit is showing results. More >

Stick with Our Fab Four for Continued Outperformance
Source: Fincom Investment Partners for Streetwise Reports  (1/11/18)
While miners have bounced off their December lows, what is in store for 2018? Fincom Investment Partners profiles a handful of companies it believes have an opportunity to double in 2018. More >

Mine's Updated Mineral Resource Contains Higher Grades
Source: Streetwise Reports  (1/11/18)
Euro Pacific Capital reviewed the new estimated resource released by this company for its Peruvian mine.
More >

Optimum Entry Point for Gold and Silver Stocks
Source: Clive Maund for Streetwise Reports  (1/11/18)
Technical analyst Clive Maund discusses why he believes a massive new sector bull market is about to begin in gold and silver. More >

Biotech Offers 'Best-in-Class Potential to Treat Alzheimer's'
Source: Streetwise Reports  (1/10/18)
André Uddin, an analyst with Mackie Research Capital Corp., discussed the implications of the latest announcement about this firm's most advanced Alzheimer's drug. More >

Biotech with Non-Statin Cholesterol Lowering Drug Poised for Significant Catalysts in 2018
Source: John McCamant for Streetwise Reports  (1/10/18)
As 2018 begins, John McCamant, editor of Medical Technology Stock Letter, reviews several 2017 top performers, discusses the turnaround at the FDA, and profiles one company with an innovative non-statin LDL cholesterol in the pipeline. More >

2018 Biotech Watchlist: 'No One Space Is Going to Dominate'
Source: Streetwise Reports  (1/10/18)
Michael King of JMP Securities provides a comprehensive round-up of companies he has selected for the 2018 Biotech Watchlist—companies in immuno-oncology, gene editing, and other indications that he believes offer promising opportunities for patients and investors.
More >

Firm Focused on Women's Health Posts 'Record' Sales of Treatment Device
Source: Streetwise Reports  (1/10/18)
A company marketing a product designed to enhance women's sexual function announced preliminary financial results for Q4/17 that caught the attention of several analysts. More >